Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 9 studies | 49% ± 18% | |
microglial cell | 6 studies | 35% ± 12% | |
oligodendrocyte precursor cell | 6 studies | 46% ± 17% | |
GABAergic neuron | 5 studies | 37% ± 18% | |
glutamatergic neuron | 5 studies | 38% ± 23% | |
astrocyte | 4 studies | 30% ± 10% | |
interneuron | 4 studies | 44% ± 22% | |
dendritic cell | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 42% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2196.60 | 2639 / 2642 | 100% | 36.95 | 705 / 705 |
intestine | 100% | 1393.95 | 966 / 966 | 100% | 25.03 | 525 / 527 |
liver | 100% | 1304.66 | 226 / 226 | 100% | 22.64 | 404 / 406 |
stomach | 99% | 724.09 | 356 / 359 | 100% | 23.98 | 286 / 286 |
thymus | 100% | 1513.25 | 653 / 653 | 99% | 20.38 | 599 / 605 |
pancreas | 100% | 896.83 | 328 / 328 | 99% | 17.61 | 176 / 178 |
breast | 99% | 903.33 | 455 / 459 | 100% | 30.48 | 1113 / 1118 |
kidney | 100% | 1369.47 | 89 / 89 | 98% | 21.78 | 887 / 901 |
skin | 99% | 1241.88 | 1791 / 1809 | 99% | 39.35 | 468 / 472 |
bladder | 100% | 766.67 | 21 / 21 | 98% | 21.84 | 494 / 504 |
esophagus | 97% | 649.30 | 1403 / 1445 | 99% | 29.36 | 182 / 183 |
lung | 95% | 776.16 | 551 / 578 | 100% | 27.58 | 1153 / 1155 |
prostate | 95% | 519.79 | 233 / 245 | 98% | 15.45 | 491 / 502 |
uterus | 95% | 827.44 | 161 / 170 | 97% | 27.33 | 443 / 459 |
ovary | 87% | 489.67 | 156 / 180 | 100% | 30.48 | 430 / 430 |
adrenal gland | 100% | 3906.49 | 258 / 258 | 84% | 13.17 | 194 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.99 | 29 / 29 |
spleen | 100% | 1872.11 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.60 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.15 | 1 / 1 |
adipose | 98% | 660.61 | 1181 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 1238.21 | 875 / 929 | 0% | 0 | 0 / 0 |
muscle | 90% | 743.49 | 726 / 803 | 0% | 0 | 0 / 0 |
heart | 89% | 505.86 | 764 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 14.29 | 70 / 80 |
blood vessel | 71% | 335.50 | 942 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015810 | Biological process | aspartate transmembrane transport |
GO_0015734 | Biological process | taurine transmembrane transport |
GO_0071470 | Biological process | cellular response to osmotic stress |
GO_0098656 | Biological process | monoatomic anion transmembrane transport |
GO_0034214 | Biological process | protein hexamerization |
GO_0001678 | Biological process | intracellular glucose homeostasis |
GO_0140361 | Biological process | cyclic-GMP-AMP transmembrane import across plasma membrane |
GO_0034702 | Cellular component | monoatomic ion channel complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005225 | Molecular function | volume-sensitive anion channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | LRRC8D |
Protein name | Volume-regulated anion channel subunit LRRC8D (Leucine-rich repeat-containing protein 5) (Leucine-rich repeat-containing protein 8D) (HsLRRC8D) Leucine rich repeat containing 8 VRAC subunit D LRRC8D protein |
Synonyms | LRRC5 UNQ213/PRO239 |
Description | FUNCTION: Non-essential component of the volume-regulated anion channel (VRAC, also named VSOAC channel), an anion channel required to maintain a constant cell volume in response to extracellular or intracellular osmotic changes . The VRAC channel conducts iodide better than chloride and can also conduct organic osmolytes like taurine . Plays a redundant role in the efflux of amino acids, such as aspartate, in response to osmotic stress . LRRC8A and LRRC8D are required for the uptake of the drug cisplatin . Channel activity requires LRRC8A plus at least one other family member (LRRC8B, LRRC8C, LRRC8D or LRRC8E); channel characteristics depend on the precise subunit composition . Also acts as a regulator of glucose-sensing in pancreatic beta cells: VRAC currents, generated in response to hypotonicity- or glucose-induced beta cell swelling, depolarize cells, thereby causing electrical excitation, leading to increase glucose sensitivity and insulin secretion (By similarity). VRAC channels containing LRRC8D inhibit transport of immunoreactive cyclic dinucleotide GMP-AMP (2'-3'-cGAMP), an immune messenger produced in response to DNA virus in the cytosol . Mediates the import of the antibiotic blasticidin-S into the cell . . |
Accessions | E9PJS7 ENST00000414841.1 ENST00000441269.2 E9PL08 ENST00000527156.1 ENST00000394593.7 ENST00000337338.9 Q96GG5 ENST00000532201.5 Q5VWA0 Q7L1W4 ENST00000525774.5 E9PMF9 E9PJ89 |